VYNE Therapeutics Balance Sheet (2016-2026) | VYNE

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
118.52M0.60M52.31M0.60M50.49M42.81M35.51M0.07M0.07M20.63M0.05M0.05M19.07M29.61M16.27M19.93M28.21M22.05M24.03M24.63M
Short-term Investments (Quarter)
1.03M62.63M66.89M48.49M53.91M41.59M22.06M17.60M4.98M0.30M
Cash & Current Investments (Quarter)
119.54M0.60M52.31M0.60M50.49M42.81M35.51M0.07M0.07M20.63M0.05M62.69M85.95M78.10M70.19M61.52M50.27M39.65M29.01M24.93M
Receivables - Net (Quarter)
10.76M10.87M10.08M7.58M0.54M0.30M0.47M0.17M0.10M0.23M0.25M
Receivables - Other (Quarter)
8.10M7.60M7.30M5.50M
Receivables (Quarter)
18.86M18.47M17.38M13.08M0.54M0.30M0.47M0.17M0.10M0.23M0.25M
Raw Materials (Quarter)
3.30M
Finished Goods (Quarter)
4.00M
Inventory (Quarter)
8.09M8.28M8.07M7.29M
Prepaid Assets (Quarter)
3.87M5.27M5.06M4.57M3.90M3.77M3.00M2.30M2.64M2.02M1.76M2.66M4.22M5.63M3.30M2.92M4.64M4.70M1.00M0.86M
Current Assets (Quarter)
143.12M128.43M76.13M63.19M60.65M51.92M44.05M38.27M33.02M22.96M17.51M95.96M90.22M83.78M73.53M64.44M54.91M44.34M30.01M25.79M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.53M0.50M0.47M0.35M0.31M0.30M0.13M0.11M0.11M0.10M0.09M0.08M
Long-Term Investments (Quarter)
Goodwill (Quarter)
Goodwill & Intangibles (Quarter)
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)
4.12M3.83M3.68M3.51M3.35M2.97M2.73M0.10M0.10M2.00M1.76M1.51M1.27M2.72M2.54M2.26M1.34M0.24M0.06M
Non-Current Assets (Quarter)
6.05M5.56M5.19M3.86M3.67M3.27M2.86M2.48M2.24M2.00M1.76M1.72M1.45M2.87M2.66M2.47M1.51M0.38M0.15M0.08M
Assets (Quarter)
149.17M133.98M81.31M67.05M64.32M55.19M46.91M40.76M35.26M24.96M19.27M97.69M91.68M86.65M76.20M66.91M56.42M44.72M30.16M25.87M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
3.49M10.08M7.62M6.51M3.61M1.43M2.52M2.39M2.21M1.16M0.72M1.66M2.79M4.52M3.99M2.71M3.53M1.41M1.04M0.26M
Notes Payables (Quarter)
Payables (Quarter)
3.49M10.08M7.62M6.51M3.61M1.43M2.52M2.39M2.21M1.16M0.72M1.66M2.79M4.52M3.99M2.71M3.53M1.41M1.04M0.26M
Accumulated Expenses (Quarter)
13.52M3.48M9.61M8.59M1.33M1.60M2.16M2.37M4.19M0.84M4.45M4.12M3.64M5.07M1.07M1.43M6.86M3.58M0.94M0.09M
Other Accumulated Expenses (Quarter)
0.10M0.10M0.10M1.31M1.31M1.31M1.31M
Short term Debt (Quarter)
33.38M
Current Leases (Quarter)
0.65M0.43M0.28M0.35M0.10M0.03M0.12M0.12M0.12M0.12M0.10M0.06M0.03M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)
21.55M57.62M21.00M18.41M9.35M7.52M6.37M6.45M7.54M6.93M11.75M12.66M14.82M12.29M5.84M2.40M1.24M
Non-Current Liabilities
Non-Current Debt (Quarter)
33.27M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Minority Interest (Quarter)
0.21M
Operating Leases (Quarter)
1.43M0.81M0.78M0.10M0.06M0.03M0.10M
Other Non-Current Liabilities (Quarter)
0.46M0.45M0.45M1.30M1.30M1.30M1.31M1.30M
Total Non-Current Liabilities (Quarter)
55.81M58.64M21.98M7.53M6.39M6.46M1.41M1.38M0.03M
Total Liabilities (Quarter)
56.27M59.09M22.43M18.41M8.59M6.83M6.84M9.35M8.83M7.69M7.76M8.95M8.31M11.78M12.66M14.82M12.29M5.84M2.40M1.24M
Shareholder's Equity
Total Debt (Quarter)
33.27M33.38M
Common Equity (Quarter)
92.90M74.89M58.89M48.64M55.73M48.36M40.07M31.20M26.43M17.27M11.51M88.73M83.37M74.87M63.54M52.09M44.13M38.88M27.77M24.64M
Liabilities and Shareholders Equity (Quarter)
149.17M133.98M81.31M67.05M64.32M55.19M46.91M40.76M35.26M24.96M19.27M97.69M91.68M86.65M76.20M66.91M56.42M44.72M30.16M25.87M
Retained Earnings (Quarter)
-586.75M-606.67M686.84M688.16M-634.90M691.68M-652.80M-668.51M-678.56M-685.15M0.03M781.02M781.92M782.65M0.02M-739.78M784.42M-757.65M
Treasury Shares (Quarter)
0.00M0.46M0.75M0.45M